Sunday, June 22, 2025

Stocks To Watch for March 10: IREDA, Gensol Engineering, Bodal Chemcials, IndusInd Bank and more

Date:

Image count1 / 9

IREDA | The Reserve Bank of India on March 7, has not acceded to the request of the company for equity investment for development and implementation of 900 MW Upper Karnali Hydro Electric Power Project in Nepal. The company will again represent the RBI in this regard.

Gensol Engineering share price

Image count2 / 9

Gensol Engineering | Promoters have sold 2.37% of their total equity or 9 lakh shares to unlock liquidity that will be reinvested into the business. Promoter had earlier told CNBC-TV18 that they would increase stake in the company soon. The board will also meet on March 13 to consider fund raising via QIP and other avenues and also consider a stock split.

IndusInd Bank share price

Image count3 / 9

IndusInd Bank | RBI has approved the reappointment of Sumant Kathpalia as MD & CEO for a year until March 23, 2026. The board of the lender had approved his reappointment for a three-year period.

Image count4 / 9

Bodal Chemicals | Government of India has recommended imposing anti-dumping duty on imports of Trichloro Isocyanuric Acid falling under tariff items 2933 69 10 or 2933 69 90 of the First Schedule of the Customs Tariff Act, 1975, originating in or exported from China and Japan. Bodal Chemicals is the producer of TCAA at its unit 11 in Khambhat. As of now, Bodal Chemicals is the only producer of TCAA products in India and this will help the company add ₹50 crore to ₹60 crore to its topline starting financial year 2025 and also improve the bottomline. The duty will be effective from five years, starting March 7.

Lupin

Image count5 / 9

Lupin | Launches Rivaroxaban tablets in the US following final drug approval for its ANDA. Rivaroxaban is used to reduce the risk of major cardiovascular events in patients with coronary artery disease.

Image count6 / 9

Tata Power | Arm Tata Power Renewable Energy signs MoU with Andhra Pradesh Government to develop up to 7,000 MW of renewable energy projects and the estimated investment in these projects is nearly ₹49,000 crore.

Image count7 / 9

Shilpa Medicare | USFDA issues form 483 with one observation for Raichur-based unit-1 of its arm Shilpa Lifesciences. The inspection was carried out between March 3-7, 2025.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

US strikes on Iran used bunker buster bombs, cruise missiles

The US military used “bunker-buster” bombs in its attack...

Iran says ‘no signs of contamination’ after US strikes nuclear facilities

Iran said early on Sunday (June 22) there were...

ITR 2025: How tax calculator can help you file your return with ease?

Income Tax Return (ITR): Before filing income tax return,...

US attacking Iran nuclear sites leaves Oil prices primed for a surge

The US has attacked Iran's nuclear facilities on Sunday,...